SLU-PP-332 500MCG ORAL TABLETS – ADVANCED METABOLIC & ENDURANCE RESEARCH FORMULATION

SLU-PP-332 by iLab Pharma is a highly selective PPARδ agonist developed for precision research into lipid metabolism, endurance optimization, and energy pathway regulation. This oral tablet format offers accurate dosing and convenience for long-term controlled studies, enabling consistent administration in experimental protocols.

By activating PPARδ—a receptor critical to oxidative metabolism—SLU-PP-332 supports enhanced fatty acid oxidation, improved mitochondrial efficiency, and greater metabolic flexibility in laboratory models. Its targeted activity allows researchers to explore performance-related biochemical pathways without triggering unrelated receptor systems.

The Details:

• Dosage: 500MCG per tablet. Research applications vary depending on experimental design.

• Quantity: 50 tablets per bottle for sustained study use.

• Packaging: Delivered in a sealed, tamper-proof container to ensure integrity and purity.

• Source: Manufactured by F40 Biotech to pharmaceutical-grade standards with third-party testing for purity, potency, and consistency.

Key Features of SLU-PP-332 500MCG Oral Tablets:

• Precise Oral Dosing: Standardized 500MCG per tablet for accurate experimental administration.

• Enhanced Fatty Acid Utilization: Supports lipid metabolism efficiency in research models.

• Improved Mitochondrial Function: Promotes oxidative energy output and cellular performance.

• Metabolic Flexibility: Facilitates adaptive energy usage in controlled studies.

• 100% Authentic & Lab-Tested: Verified by independent analysis for purity and quality.

For more products, visit: https://www.canadasteroiddepot.is/